Just Select Correct Options & Calculate Best Price ✅
Result is all that Matters!
Just type it — or tap one below.
A rough idea is fine · 1 page ≈ 250 words.
Confirming writer availability for your deadline.
Doctoral-level support for cancer nursing research. NMC-registered PhD writers with Macmillan, CRUK, UKONS experience. Specialists in chemotherapy administration, immunotherapy nursing, haematology, late effects, survivorship, supportive cancer care, palliative oncology, and cancer pathway research. Royal Marsden / Christie / UCLH / Beatson clinical heritage. ZERO AI. Since 2001.
A PhD in Oncology / Cancer Nursing is a 3–4 year UK research degree culminating in an original 60,000–80,000-word thesis on a topic relevant to cancer nursing practice, survivorship, supportive care, palliative oncology, or the cancer pathway. UK oncology nursing PhDs are funded by NIHR DRF / ICA, Cancer Research UK (CRUK), Macmillan Cancer Support, Marie Curie, MRC, Wellcome, Yorkshire Cancer Research, RCN Foundation, or NHS Trust-sponsored schemes through major cancer centres including the Royal Marsden, Christie, UCLH, Beatson, Belfast Cancer Centre, Velindre, and Edinburgh Cancer Centre.
Whether you need a single chapter or end-to-end thesis support, our oncology nursing PhD team writes every standard UK doctoral chapter to journal-publication standard. Each chapter below can be ordered individually or as part of full thesis support.
250–350 word doctoral abstract following CONSORT / PRISMA structure: background, aims, methods, results, conclusion, implications. Dedicated abstract service ›
500–1,500 word executive summary used for upgrade panels and viva preparation. Dedicated synopsis service ›
Context-setting chapter: cancer epidemiology, NHS Cancer Plan, research problem, aims, objectives, RQs, thesis structure. Dedicated introduction service ›
Critical synthesis of cancer nursing literature. PRISMA-aligned structured search across CINAHL, MEDLINE, EMBASE, PsycINFO, Cochrane. PhD literature review service ›
Epistemology, research design, sampling, recruitment via cancer MDTs, ethics navigation, data collection, analytic approach. Methodology service ›
Cancer-specific frameworks: Cancer Survivorship Continuum, Symptom Management Theory, Self-Regulation Theory, PRECEDE-PROCEED. Framework support ›
Quantitative (SPSS, STATA, R) or qualitative (NVivo IPA / TA) analysis. Tables, forest plots, themes, framework matrices. Results & discussion service ›
Theoretical interpretation, comparison with literature, oncology nursing implications, NICE / NHS Cancer Plan alignment. Discussion service ›
Separate findings chapter for qualitative work or mixed-methods integration. Findings service ›
Summary of contribution, limitations, recommendations for practice, policy, education, future research. Conclusion service ›
Harvard, Vancouver, APA 7th, or university-specific referencing. Managed in EndNote, Mendeley, or Zotero.
IRAS forms, PIS / consent, interview schedules, instruments, PRISMA flow, data extraction templates, ethics correspondence.
Funder, supervisor, participant, PPI advisor, family acknowledgements drafted to your school style.
NMC-aligned authenticity statement, AI-use declaration, conflict of interest, ethics approval citation.
School-specific class file, table of contents, list of figures/tables, page numbering, headers/footers. Formatting service ›
Minor or major corrections post-viva, examiner-response document, revised thesis preparation. Corrections service ›
HRA / REC for cancer research, MDT recruitment pathway, NHS Cancer Alliance liaison, Trust R&D for cancer studies, NCRAS data access.
PRISMA 2020 systematic reviews on cancer nursing topics. PROSPERO. Cochrane Gynaecological, Breast, Haematological Cancers Groups. Macmillan-aligned evidence synthesis.
Survivorship continuum research (Mullan stages), late effects (cardiotoxicity, secondary cancers, infertility), Living With and Beyond Cancer programme, NHS Cancer Recovery package.
EORTC QLQ-C30 + site-specific modules (BR23, LC13, CR29), FACT-G + FACT-B/L/C, HADS, Distress Thermometer, MMAS-8 for oral adherence, Concerns Checklist.
CONSORT-compliant trial protocols for nurse-led interventions, prehabilitation, exercise oncology, psychosocial interventions, supportive care, complementary therapies.
Framed against NHS Long Term Plan Cancer Programme, NHS Cancer Strategy, NCRAS data, NHS Galleri trial, Faster Diagnosis Standard, NICE NG12 (suspected cancer), NG101 (early/locally advanced breast).
Systemic anti-cancer therapy administration, OCNA standards, extravasation, neutropenic sepsis, immune-related adverse events, oral SACT adherence, ambulatory chemo.
Checkpoint inhibitor nursing, CAR-T cell therapy, cytokine release syndrome (CRS), ICANS, immune-related adverse events, novel agent nursing.
Leukaemia, lymphoma, myeloma, stem cell transplant (auto/allo), CAR-T, BMT recovery, graft-versus-host disease, CMV monitoring, MRD assessment.
Living With and Beyond Cancer, recovery package, holistic needs assessment (HNA), care plan, treatment summary, late effects clinic, return-to-work.
Symptom control, breakthrough pain, total pain (Saunders), MND care for cancer cachexia, prognostication, ICD-10 cancer mortality coding.
Enhanced recovery oncology (ERAS-O), prehabilitation, stoma care, breast surgery nursing, head and neck cancer nursing, gynae oncology.
Radical and palliative radiotherapy, side effects (skin, fatigue, oral mucositis), proton beam therapy, brachytherapy, stereotactic radiosurgery (SRS).
CCLG-aligned research, paediatric chemotherapy, late effects of childhood cancer, transitional care 16-25, paediatric palliative oncology.
Using SF-36 instead of EORTC QLQ-C30 misses cancer-specific concerns. Examiners reject this.
Survivors who attend follow-up clinics differ from those who don't. Examiners probe sample representativeness.
Charity strategic priorities shape funding decisions and policy. Ignoring them weakens impact discussion.
Cancer outcomes differ substantially by ethnicity, deprivation, geographic region. Modern viva expects this engagement.
Specific audience: cancer MDT nursing leads, Macmillan, CNS networks, UKONS, NHS Cancer Alliance teams.
Justify EORTC QLQ-C30 vs SF-36, site-specific module choice, distress thermometer cut-offs.
Engage Core20PLUS5, ethnic minority cancer outcomes, deprivation gradient, late-stage diagnosis in deprived areas.
Faster Diagnosis Standard, 75% by 2028 early diagnosis ambition, personalised care, recovery package.
Risk-stratified follow-up, supported self-management, personalised stratified follow-up (PSFU), nurse-led clinics.
"CAR-T cell therapy nursing thesis. Their CRS / ICANS knowledge was clinically authoritative."
"Macmillan-aligned recovery package research. Examiner praised the policy currency."
"Allogeneic SCT recovery thesis. GvHD nursing care chapter went to publication."
"Cancer cachexia nursing intervention. Beautifully framed with total pain theory."
30-min consultation with cancer-experienced PhD nurse. Align with current Cancer Alliance and Macmillan priorities.
HRA, REC, NCRAS data access, MDT recruitment pathway, Trust R&D for cancer studies, PROSPERO registration.
CINAHL + MEDLINE + EMBASE + Cochrane Cancer + PsycINFO searches; dual-reviewer Rayyan; ROB 2.0.
Cancer-specific outcome measures, EORTC modules, recruitment via cancer MDTs, statistical analysis planning.
SPSS / STATA survival analysis; NVivo IPA. Findings framed against NHS LTP Cancer, NICE NG12, Macmillan priorities.
Thesis formatting, mock viva with senior cancer nurse academic, post-viva corrections.
King's College London (Florence Nightingale Faculty + Cancer Centre at Guy's), University of Manchester (Christie partnership), University of Southampton (cancer nursing strong), Cardiff University (Velindre partnership), UCL Cancer Institute.
Royal Marsden / ICR BRC, Manchester / Christie BRC, UCLH / Cancer Institute BRC, Cambridge Cancer Centre, Oxford Cancer BRC, Birmingham BRC Cancer Theme, Leeds Cancer Research UK Centre.
City St George's University of London, University of West London, Edge Hill, Northumbria, Salford, Anglia Ruskin, Brighton, Bournemouth, University of Surrey, Liverpool John Moores.
Royal Marsden School of Cancer Nursing, Christie School of Oncology, Macmillan-funded PhD pathways, CCLG-linked paediatric oncology PhDs.
CAR-T cell therapy nursing, CRS management, ICANS recognition, checkpoint inhibitor irAEs, novel agent administration safety.
Living With and Beyond Cancer, personalised stratified follow-up (PSFU), HNA implementation, supported self-management, late-effects clinics.
Core20PLUS5 cancer priorities, Black, Asian, ethnic minority cancer outcomes, deprivation gradient, late-stage diagnosis, geographic inequalities.
NHS Galleri trial, FIT screening, NG12 implementation, faster diagnosis standard, GP cancer referral, lung CT screening pilots.
Pre-treatment fitness optimisation, exercise oncology, nutritional prehab, psychological prehab, ERAS-O, surgical readiness.
Remote monitoring, eHealth apps, patient-reported outcomes platforms (e.g. ePROs), virtual oncology consultations, AI in cancer triage.
CNS workforce, OCNA-trained workforce expansion, Macmillan workforce census, advanced cancer nurse roles, return-to-cancer-nursing.
CCLG late effects research, cardiotoxicity, infertility, secondary cancers, neurocognitive outcomes, transitional cancer care 16-25.
Palliative care nursing, adult nursing assignment, nursing case study, nursing care plan.
PhD Nursing hub, PhD Adult Nursing, PhD Palliative Care, PhD Critical Care.
PhD Paediatric Nursing, PhD Public Health Nursing, PhD Thesis Hub.
Essay writing UK, PhD essay writing, Master's essay, Assignment help UK.
A PhD in Oncology / Cancer Nursing is a 3–4 year UK research degree producing an original 60,000–80,000-word thesis on cancer nursing practice, survivorship, palliative oncology, or supportive cancer care. Funded by NIHR DRF, CRUK, Macmillan, MRC, Marie Curie, or Trust schemes.
Yes. Our oncology nursing PhD team includes Macmillan-aligned and CRUK-experienced nurses with NHS oncology and haematology experience at Royal Marsden, Christie, UCLH, Beatson, Belfast Cancer Centre, and Velindre.
Yes. We help with NHS Digital cancer registration data access, NCRAS Public Health England cancer outcomes, Cancer Patient Experience Survey (CPES) analysis, and Routes to Diagnosis data.
Yes. UKONS SACT competence framework, OCNA chemotherapy administration standards, immunotherapy nursing competencies, CAR-T cell therapy nursing all covered.
5–9 months chapter-by-chapter for a 60,000–80,000 word thesis.
Yes. ZERO AI. Turnitin and AI-detection reports with every chapter.
From CAR-T immunotherapy to survivorship to childhood cancer late effects, our Macmillan / CRUK-aligned PhD team supports UK oncology nursing doctoral candidates. ZERO AI. Since 2001.
Projectsdeal is Gold Standard in Academic Research & Writing
Verified by Turnitin & AI Detectors to ensure 100% original, human-written content.
Every year if more than 80% of your own class can afford it, you can surely!
Our Guarantees ensure Guaranteed Grades!
Dedicated Personal Managers to ensure high level of service experience.
Give us any number of modifications; we care for your success.
Follow Strict Code of Confidentiality.
On-time delivery guaranteed. Sit back and relax!